SEC Form 4 · accession 0001127430-18-000068
INSMED Inc · INSM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steinar J Engelsen
Director
Period of report
Nov 1, 2018
Accepted (ET)
Nov 2, 2018 · 4:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001104506
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 1, 2018 | P | 16,085 | $15.7907 | A | 281,303 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $15.60 to $15.93. The price reported above reflect the weighted average price. The number of shares sold at each separate price will be made available to the SEC staff, the issuer or a security holder of the issuer upon request.